This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 May;59(5):607-10.

doi: 10.1053/j.ajkd.2011.11.017. Epub 2011 Dec 7.

Fibroblast growth factor 23 and CKD prognosis

Navdeep Tangri¹, Andrew S Levey

Affiliations

PMID: 22153824
DOI: 10.1053/j.ajkd.2011.11.017

Comment

Fibroblast growth factor 23 and CKD prognosis

Navdeep Tangri et al. Am J Kidney Dis. 2012 May.

. 2012 May;59(5):607-10.

doi: 10.1053/j.ajkd.2011.11.017. Epub 2011 Dec 7.

Authors

Navdeep Tangri¹, Andrew S Levey

Affiliation

¹ University of Manitoba, Winnipeg, Manitoba, Canada. ntangri@sogh.mb.ca

PMID: 22153824
DOI: 10.1053/j.ajkd.2011.11.017

No abstract available

PubMed Disclaimer

Comment on

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.
Isakova T, Xie H, Yang W, Xie D, Anderson AH, Scialla J, Wahl P, Gutiérrez OM, Steigerwalt S, He J, Schwartz S, Lo J, Ojo A, Sondheimer J, Hsu CY, Lash J, Leonard M, Kusek JW, Feldman HI, Wolf M; Chronic Renal Insufficiency Cohort (CRIC) Study Group. Isakova T, et al. JAMA. 2011 Jun 15;305(23):2432-9. doi: 10.1001/jama.2011.826. JAMA. 2011. PMID: 21673295 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science